Examkin

Soru

Zorluk: OrtaPharmacologic Interventions

A 62-year-old man with chronic kidney disease stage 4 presents to the emergency department reporting progressive, severe muscle weakness over the past 24 hours. He recently started taking lisinopril and spironolactone for hypertension and heart failure. His pulse is 48/min, and blood pressure is 105/65 mm Hg. An electrocardiogram reveals peaked T waves and a widened QRS complex. Stat laboratory results show a serum potassium level of 7.6 mEq/L. Arrange the following pharmacologic interventions in the most appropriate chronological order of administration for the acute management of this patient's condition.

  1. 1Intravenous calcium gluconate
  2. 2Intravenous regular insulin and dextrose
  3. 3Oral sodium zirconium cyclosilicate

Cevap

The correct sequence of pharmacologic interventions is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and dextrose, 3) Oral sodium zirconium cyclosilicate.
In patients with severe hyperkalemia and characteristic electrocardiographic changes (especially a widened QRS complex), the immediate priority is to prevent fatal cardiac arrhythmias. This requires a sequential approach: Stabilize, Shift, and Excrete. Intravenous calcium gluconate is administered first because it acts within 1-3 minutes to stabilize the myocardial cell membrane by raising the threshold potential. Next, intravenous insulin (given with dextrose to prevent hypoglycemia) is administered to rapidly shift potassium into cells by stimulating the Na+/K+-ATPase pump, which temporarily lowers serum levels within 15-30 minutes. Finally, a gastrointestinal potassium binder like oral sodium zirconium cyclosilicate is administered to permanently excrete the excess potassium from the body over several hours.

Adım Adım Çözüm

1
Identify the life-threatening condition requiring immediate intervention.
The patient has severe hyperkalemia (7.6 mEq/L) with characteristic electrocardiographic changes (peaked T waves, widened QRS), posing an imminent risk of fatal arrhythmias.
Recognizing the severity of hyperkalemia dictates the urgency and prioritization of the treatment algorithm.
2
Determine the absolute first pharmacologic priority.
Intravenous calcium gluconate must be given immediately.
Calcium antagonizes the membrane actions of hyperkalemia, stabilizing the cardiac resting membrane potential before ventricular fibrillation or asystole can occur.
3
Determine the subsequent steps to actively lower serum potassium.
Insulin and dextrose are given next to shift potassium intracellularly, followed by a potassium binder (sodium zirconium cyclosilicate) to physically remove it from the body.
Intracellular shifting provides rapid but temporary relief, while gastrointestinal binders provide slow but permanent elimination of the total body potassium load.

Anahtar Kavram

The acute management of severe hyperkalemia with electrocardiographic changes follows a strict, sequential algorithm: 1) myocardial membrane stabilization (calcium), 2) rapid intracellular shifting (insulin/dextrose, beta-agonists), and 3) total body potassium elimination (gastrointestinal binders, diuretics, or hemodialysis).
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru